Navigation Links
Atrium Innovations to Hold 2007 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast on February 29
Date:2/14/2008

QUEBEC CITY, Feb. 14 /PRNewswire-FirstCall/ - Atrium Innovations Inc. (TSX: ATB) will hold its quarterly conference call and webcast at 1:30 p.m. Eastern time on February 29, 2008. The call will follow the press release of Atrium's 2007 fourth quarter and full year results issued earlier that day. Participants may access the call by using the following numbers: 416-644-3420, 514-807-8791 or 800-731-5774 or via the Company's website at http://www.atrium-innov.com in the "Investors" section.

A replay of the webcast will also be available on our website http://www.atrium-innov.com in the "Investors" section for a period of 30 days.

About Atrium

Atrium Innovations Inc. is a recognized leading developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutrition industries. The Company focuses primarily on growing segments of the health and personal care markets which are benefiting from the trends towards healthy living and the ageing of the population. Atrium markets a broad portfolio of active ingredients, specialty chemicals and health and nutrition finished products through its highly specialized sales and marketing network in more than 50 countries, primarily in North America, Europe and Asia. Atrium has over 600 employees and operates four manufacturing facilities. Additional information about Atrium is available on its Web site at http://www.atrium-innov.com.

Cautionary Note and Forward-Looking Statements

This press release contains certain forward-looking statements with respect to the Company. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by these forward-looking statements. The Co
'/>"/>

SOURCE Atrium Innovations Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
2. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
3. Atrium Innovations Announces Management Changes
4. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
5. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
6. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
7. Ten Extraordinary Innovations Line Up For US $100,000 Saatchi & Saatchi Award For World Changing Ideas
8. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
9. Inverness Medical Innovations Acquires ParadigmHealth
10. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
11. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 PI’s new LPS-24 ... provide 15 mm travel range with closed-loop sensor ... dimensions make these new positioners the ideal choice ... vacuum rated version is also available. , ... datasheets can be found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 On April ... trips to supermarkets to search for the growing antibiotic ... aisles. Results from a year long study were released ... in foods, specifically meats, over previous years. For those ... the growth of antibiotic resistant bacteria in food, may ...
(Date:5/23/2013)... May 23, 2013  Verenium Corporation (Nasdaq: ... the development and commercialization of high-performance enzymes, today announced ... Officer, will present at two upcoming conferences. ... present at the Second Annual Marcum LLP Microcap Conference ... Hotel in New York City.  The presentation is scheduled ...
(Date:5/23/2013)... 2013 Bed bugs already cost Alton Housing ... still ongoing, a report from kmov.com suggested that the said ... bug treatment. Meanwhile, to be of help, My Cleaning Products ... bed bug exterminator service. , The report, which ... so far spent $35,000 for bed bug elimination, ...
Breaking Biology Technology:Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2
... June 19 Isolagen(TM), Inc. announced on June 16, ... Company,s wholly owned subsidiary, each filed a voluntary petition ... Bankruptcy Code in the United States Bankruptcy Court for ... and Isolagen Technologies intend to continue to manage and ...
... , , , Industry ... Clinical Sites, Research Sponsors and Regulators through Utilization of ... Greenway Medical Technologies, a leading provider of an ... solution, today announced its participation in the Drug Information ...
... conducted by Novartis evaluating safety and efficacy of Albuferon administered ... genotypes 2 and 3 hepatitis C - , , ... HGSI ) today announced that Novartis has completed ... to evaluate the safety and efficacy of Albuferon(R) (albinterferon alfa-2b) ...
Cached Biology Technology:Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 2Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 3Greenway Medical Technologies To Display Live Interoperability Implementations at 2009 DIA Show 2Greenway Medical Technologies To Display Live Interoperability Implementations at 2009 DIA Show 3Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R) 2Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R) 3Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R) 4
(Date:5/22/2013)... bacteria is responsible for legionellosis, an infectious disease that ... this pathogen has developed a complex method enabling it ... thus avoiding these acting against the infectious bacteria. , ... bioGUNE, in which teams from the National Institute of ... Centre in Barcelona (BSC) have also participated, has described ...
(Date:5/21/2013)... for a long time that some creatures evolve more ... for plants. But it may be that height plays ... and the U. S. National Evolutionary Synthesis Center. ... in the journal Nature Communications , Lanfear and ... Drawing from a database of global patterns in plant ...
(Date:5/21/2013)... of pharmaceuticals can both prevent and treat Alzheimer,s Disease ... ligands," are currently used for certain types of neuroimaging. ... in young adult mice when pathology was at an ... quite severe," said lead researcher Christian Pike of the ... of pathology and improved behavior at both ages." , ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Small but speedy: Short plants live in the evolutionary fast lane 2Drugs found to both prevent and treat Alzheimer's disease in mice 2
... Ga. Predicting the risk of extinction is a complicated ... sites. Researchers at the University of Georgia and Tulane University ... more accurate. Their work appears in the early online edition ... "The concern is that for a lot of species, we ...
... and why students smoke might lead to the development of ... Missouri. In an article published in the journal ... partying, drinking and work prompted college students to recall their ... start of the semester and on weekends. "Students ...
... Washington, D.C.-- New research suggests a pattern of outpatient ... in the Southeast --a problem that could accelerate the ... according to Extending the Cure, a project of the ... findings come out just as the Centers for Disease ...
Cached Biology News:New model more accurately describes migratory animals' extinction risk 2Research reveals when and why students smoke in effort to help them quit 2Alarming pattern of antibiotic use in the southeastern United States 2Alarming pattern of antibiotic use in the southeastern United States 3
... Recombinant Enterokinase (rEK) is a highly purified ... enterokinase, a serine protease which recognizes the ... (AspAspAspAspLys?) and has similar enzymatic activity (1). ... and purified to yield the highest activity ...
Angiotensin Converting Enzyme [Porcine Kidney, ACE, Peptidyl-dipeptidase A]...
The bench-top stand comfortably holds up to 6 Finnpipette Digital single- and multichannel pipettes. The crossbars are made of a grippy material to keep the pipettes firmly in place. Individual shelf...
... a serine/threonine phosphatase isolated from human red ... heterodimer of 60kDa (A) and 36kDa (C) ... the a-subunit of phosphorylase kinase. With its ... specificity and may play a regulatory role ...
Biology Products: